Category:Anti-SLAMF7 antibodies
Revision as of 20:01, 27 February 2020 by Warner-admin (talk | contribs) (Text replacement - "Category:Antibody medications" to "Category:Antineoplastic monoclonal antibodies")
Drugs that have some demonstrated degree of efficacy through the inhibition of Signaling Lymphocytic Activation Molecule Family member 7 (SLAMF7), also commonly called CS1. Elotuzumab is the first FDA-approved medication in this category.
Pages in category "Anti-SLAMF7 antibodies"
This category contains only the following page.